Loading...
Suboptimal Responses in Chronic Myeloid Leukemia
The high response rates and increased survival associated with imatinib therapy prompted a paradigm shift in the management of chronic myeloid leukemia. However, 25% to 30% of imatinib-treated patients develop drug resistance or intolerance, increasing the risk of disease progression and poor progno...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wiley Subscription Services, Inc., A Wiley Company
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3412948/ https://ncbi.nlm.nih.gov/pubmed/22038681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26391 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|